News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chemokine Therapeutics Corp. (CTI.TO) Launches Strategic Financial Initiative


9/24/2008 9:21:47 AM

VANCOUVER, BRITISH COLUMBIA--(Marketwire - September 24, 2008) - Chemokine Therapeutics Corp. (the "Company") (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, today announced the launch of a multi-stage strategic financial initiative. The initiative is designed to (1) address current working capital needs, (2) raise required funds for the launch of the CTCE-9908 Phase II liver cancer trial and (3) materially enhance shareholder value.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES